Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
898.00    2.00 (0.22%)
Bid:
904.00
Ask:
906.00
Spread: 2.00 (0.221%)
Market Cap: £129.20b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Pre Stabilisation Notice

6 Feb 2019 08:40

RNS Number : 2323P
HSBC Bank plc
06 February 2019
 

6th Feb 2019

 

Banco Santander, S.A. (the "Bank")

Stabilisation Notice

 

HSBC (contact: 'Syndicate desk'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Banco Santander, S.A. (the "Bank")

Guarantor (if any):

Aggregate nominal amount:

Bmk

Description:

USD Perp NC5 AT1

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

CACIB/Credit Suisse/ Deutsche Bank /HSBC/Santander

Stabilisation period expected to start on:

6th Feb 2018

Stabilisation period expected to end no later than:

6th March 2018

Existence, maximum size & conditions of use of over-allotment facility:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEUGUAWPUPBURQ
Date   Source Headline
5th Feb 20265:34 pmRNSDirector/PDMR Shareholding
5th Feb 20265:32 pmRNSDirector/PDMR Shareholding
4th Feb 20267:43 amRNSCommencement of a program to repurchase own shares
4th Feb 20267:00 amRNS2025 Results - Press release
4th Feb 20267:00 amRNSNotice of presentation to analysts
4th Feb 20267:00 amRNS2025 Financial report & Earnings presentation
3rd Feb 20266:28 pmRNSSantander to acquire Webster Bank for $12.2 bn
2nd Feb 202612:11 pmRNSTotal Voting Rights
28th Jan 202610:03 amRNSNotice of 2025 Results Presentation
13th Jan 20265:28 pmRNSDirector/PDMR Shareholding
31st Dec 202510:46 amRNSTotal Voting Rights
31st Dec 202510:46 amRNSTotal Voting Rights
30th Dec 20254:32 pmRNSFurther re Capital reduction
30th Dec 20254:32 pmRNSFurther re Capital reduction
23rd Dec 20256:23 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:23 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:21 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:21 pmRNSDirector/PDMR Shareholding
23rd Dec 20254:42 pmRNSTotal Voting Rights
23rd Dec 20254:42 pmRNSTotal Voting Rights
23rd Dec 202511:08 amRNSCapital reduction following completion of program
23rd Dec 202511:08 amRNSCapital reduction following completion of program
19th Dec 20253:31 pmRNSDirector/PDMR Shareholding
19th Dec 20253:31 pmRNSDirector/PDMR Shareholding
18th Dec 202511:11 amRNSBuyback programme: transactions 11-17dec
11th Dec 20255:53 pmRNSDirector/PDMR Shareholding
11th Dec 202511:07 amRNSBuyback programme: transactions 4-10dec
4th Dec 202511:05 amRNSBuyback programme: transactions 27nov-3dec
2nd Dec 20257:00 amRNSCompletion of an accelerated placement of shares
1st Dec 20254:42 pmRNSTotal Voting Rights
27th Nov 202511:07 amRNSBuyback programme: transactions 20-26nov
21st Nov 20252:09 pmRNSDirector/PDMR Shareholding
20th Nov 202511:08 amRNSBuyback programme: transactions 13-19 nov
17th Nov 20259:13 amRNSOptional Early Redemption ISIN XS2102912966
13th Nov 202511:10 amRNSBuyback programme: transactions 6-12nov
7th Nov 20254:58 pmRNSDirector/PDMR Shareholding
7th Nov 20254:56 pmRNSDirector/PDMR Shareholding
6th Nov 202511:08 amRNSBuyback programme: transactions 30Oct-5nov
6th Nov 202510:55 amRNSDirector/PDMR Shareholding
31st Oct 202511:45 amRNSTotal Voting Rights
31st Oct 20257:00 amRNSSREP Capital Requirements 2025
30th Oct 202511:06 amRNSBuyback programme: transactions 23-29Oct
29th Oct 20257:00 amRNS3Q 2025 Financial report & Earnings presentation
29th Oct 20257:00 amRNS3Q 2025 Results - Press release
23rd Oct 202511:07 amRNSBuyback programme: transactions 16-22Oct
22nd Oct 202511:11 amRNSThird Quarter 2025 Results Notice
16th Oct 202511:12 amRNSBuyback programme: transactions 9-15Oct
9th Oct 202511:05 amRNSBuyback programme: transactions 2-8Oct
3rd Oct 20252:58 pmRNSMoody's has upgraded Santanders rating
2nd Oct 20255:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.